Correlation Between Israel Corp and Novolog Pharm

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Israel Corp and Novolog Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel Corp and Novolog Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Israel Corp and Novolog Pharm Up 1966, you can compare the effects of market volatilities on Israel Corp and Novolog Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel Corp with a short position of Novolog Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel Corp and Novolog Pharm.

Diversification Opportunities for Israel Corp and Novolog Pharm

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Israel and Novolog is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Israel Corp and Novolog Pharm Up 1966 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novolog Pharm Up and Israel Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel Corp are associated (or correlated) with Novolog Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novolog Pharm Up has no effect on the direction of Israel Corp i.e., Israel Corp and Novolog Pharm go up and down completely randomly.

Pair Corralation between Israel Corp and Novolog Pharm

Assuming the 90 days trading horizon Israel Corp is expected to generate 0.87 times more return on investment than Novolog Pharm. However, Israel Corp is 1.14 times less risky than Novolog Pharm. It trades about -0.01 of its potential returns per unit of risk. Novolog Pharm Up 1966 is currently generating about -0.02 per unit of risk. If you would invest  11,986,200  in Israel Corp on September 13, 2024 and sell it today you would lose (2,097,200) from holding Israel Corp or give up 17.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Israel Corp  vs.  Novolog Pharm Up 1966

 Performance 
       Timeline  
Israel Corp 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Israel Corp are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Israel Corp sustained solid returns over the last few months and may actually be approaching a breakup point.
Novolog Pharm Up 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Novolog Pharm Up 1966 are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Novolog Pharm sustained solid returns over the last few months and may actually be approaching a breakup point.

Israel Corp and Novolog Pharm Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Israel Corp and Novolog Pharm

The main advantage of trading using opposite Israel Corp and Novolog Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel Corp position performs unexpectedly, Novolog Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novolog Pharm will offset losses from the drop in Novolog Pharm's long position.
The idea behind Israel Corp and Novolog Pharm Up 1966 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume